Breast Cancer Research and Treatment

Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis

Slavko Rogan, Jan Taeymans, Helena Luginbuehl, Martina Aebi, Sara Mahnig, Nick Gebruers

Bilateral mastectomy and the retreat from breast-conserving surgery

Frederick L. Moffat Jr., Danny Yakoub

Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines

Xiao-Long Qian, Hannah Y. Wen, Yi-Ling Yang, Feng Gu, Xiao-Jing Guo, Fang-Fang Liu, Lanjing Zhang, Xin-Min Zhang, Li Fu

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

Alaa Tarig Alshareeda, Ola H. Negm, Mohammed A. Aleskandarany, Andrew R. Green, Christopher Nolan, Patrick J. TigHhe, Srinivasan Madhusudan, Ian O. Ellis, Emad A. Rakha

Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma

Cheol Keun Park, Woo Hee Jung, Ja Seung Koo

Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors

Ivana Sestak, Mitch Dowsett, Sean Ferree, Frederick L. Baehner, Jack Cuzick

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy

Alessandra Gennari, Dino Amadori, Emanuela Scarpi, Alberto Farolfi, Angelo Paradiso, Anita Mangia, Nicoletta Biglia, Lorenzo Gianni, Amelia Tienghi, Andrea Rocca, Roberta Maltoni, Giancarlo Antonucci, Paolo Bruzzi, Oriana Nanni

Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622

Anne F. Schott, William E. Barlow, Catherine H. Van Poznak, Daniel F. Hayes, Carol M. Moinpour, Danika L. Lew, Philip A. Dy, Evan T. Keller, Jill M. Keller, Gabriel N. Hortobagyi

A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen

Harriet Johansson, Sara Gandini, Davide Serrano, Jennifer Gjerde, Monia Lattanzi, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Gunnar Mellgren, Ernst Lien, Andrea DeCensi, Bernardo Bonanni

Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426)

Erica T. Warner, Karla V. Ballman, Carrie Strand, Judy C. Boughey, Aman U. Buzdar, Lisa A. Carey, William M. Sikov, Ann H. Partridge

Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study

Marilyn L. Kwan, Song Yao, Valerie S. Lee, Janise M. Roh, Qianqian Zhu, Isaac J. Ergas, Qian Liu, Yali Zhang, Susan E. Kutner, Charles P. Quesenberry Jr., Christine B. Ambrosone, Lawrence H. Kushi

A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago

Talia Donenberg, Humayun Ahmed, Robert Royer, Shiyu Zhang, Steven A. Narod, Sophia George, Mohammad R. Akbari, Jameel Ali, Judith Hurley

Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women

Fred K. Tabung, Susan E. Steck, Angela D. Liese, Jiajia Zhang, Yunsheng Ma, Karen C. Johnson, Dorothy S. Lane, Lihong Qi, Linda Snetselaar, Mara Z. Vitolins, Judith K. Ockene, James R. Hebert

Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab

Ines Vaz-Luis, Nancy U. Lin, Nancy L. Keating, William T. Barry, Joyce Lii, Harold J. Burstein, Eric P. Winer, Rachel A. Freedman

Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study

Jonine D. Figueroa, Ruth M. Pfeiffer, Louise A. Brinton, Maya M. Palakal, Amy C. Degnim, Derek Radisky, Lynn C. Hartmann, Marlene H. Frost, Melody L. Stallings Mann, Daphne Papathomas, Gretchen L. Gierach, Stephen M. Hewitt, Maire A. Duggan, Daniel Visscher, Mark E. Sherman

Lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer

William B. Grant

Author’s response to “letter to the editor: lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer”

Christine Leopold

UK Breast Cancer Research Symposium 2016: Submitted Abstracts

Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

Andrew R. Green, D. Soria, D. G. Powe, C. C. Nolan, M. Aleskandarany, M. A. Szász, A. M. Tőkés, G. R. Ball, J. M. Garibaldi, E. A. Rakha, J. Kulka, I. O. Ellis

Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer

Kenneth L. Kehl, Chan Shen, Jennifer K. Litton, Banu Arun, Sharon H. Giordano